HRR - Task - Testing of Next Generation of Monitoring Tools for Deep Space & Planetary Exploration

NASA Logo Human Research Roadmap HRP Exploration Data

Evidence MDRP Risks Gaps Tasks Reports

Explore Search

- BMed-102
  - BMed
- CBS-BMed2
  - BMed
- Sleep Gap 1
  - Sleep
- Team Gap 2
  - Team
- Team-102
  - Team

Testing of Next Generation of Monitoring Tools for Deep Space & Planetary Exploration

Last Published: 03/26/21 03:34:00 PM (Central)

Task Book: Entry Unavailable
Principal Investigator: TBD

Short Title: Next Gen Monitoring Tools

Responsible HRP Element: Human Factors and Behavioral Performance

Collaborating Org(s):

Funding Status: Planned-Funded - Task expected to be within budget

Procurement Mechanism(s):

Directed

Aims:
The purpose of this effort is to evaluate unobtrusive measures of performance, relative to established measures (e.g. Cognition), and to provide guidelines for interpreting these ‘Next Gen’ measures. While reliable and valid objective (and subjective) measures are needed for the Bmed Risk to move from ‘red’ to ‘yellow’, future missions of extended duration will also have increasingly autonomous crews. Hence, providing measures which are unobtrusive and minimize the time burden to the crew, will provide a means through which changes in behavioral health and performance can be assessed. The intent is not to provide a measure through which crew are being monitored 24/7, but rather a measure which will cue the ground if downward trends persist.

This effort will contribute to gap closure by providing acceptable measures which will yield a set of mission acceptable thresholds of individual behavioral health and performance for exploration class missions.

Resources (Ground Analog)

Deliverables (1)

Category: Technology or Tool
Subcategory: Informatics

Description:
This effort will provide recommendations for using unobtrusive measures as a means through which to measure changes in behavior and/or performance (e.g. performance errors on ROBoT aligned with performance errors on Cognition). Guidelines for interpreting data and providing meaningful output to end users, will be provided.

Internal Customers:
Human Factors and Behavioral Performance
External Customers:
Med Ops - Medical Operations
Office of Chief Health and Medical Officer (OCHMO)

Is a Customer-Supplier Agreement (CSA) Required? No

Mappings

Risk of Adverse Cognitive or Behavioral Conditions and Psychiatric Disorders

BMed-102: Given exposures to spaceflight hazards (space radiation, isolation), how do we identify individual susceptibility, monitor molecular/biomarkers and acceptable thresholds, and validate behavioral health and CNS/neurological/neuropsychological performance measures and domains of relevance to exploration class missions?

Testing of Next Generation of Monitoring Tools for Deep Space & Planetary Exploration

Risk of Performance and Behavioral Health Decrements Due to Inadequate Cooperation, Coordination, Communication, and Psychosocial Adaptation within a Team

Team-102: We need to identify a set of quantifiable and validated measures, based on 5-12 key indicators of mission-relevant and identified spaceflight acceptable thresholds (or ranges) of team function, to effectively monitor and measure team health and performance of integrated NASA and commercial/private crews, during shifting autonomy in increasingly earth independent, long duration exploration missions.

Testing of Next Generation of Monitoring Tools for Deep Space & Planetary Exploration

Related Tasks (329)

Ground-Based Flight Analogs Controlled Research Analog, Long Duration (4 months or more) – isolated and confined with spaceflight mission scenario [e.g., NEK/Russian Chamber] Controlled Research Analog, Short Duration (2 months or less) – isolated and confined with spaceflight mission scenario [e.g., HERA, NEEMO]
Number of Subjects	38

Common Item(s)
	Risk of Adverse Cognitive or Behavioral Conditions and Psychiatric Disorders
	BMed-102: Given exposures to spaceflight hazards (space radiation, isolation), how do we identify individual susceptibility, monitor molecular/biomarkers and acceptable thresholds, and validate behavioral health and CNS/neurological/neuropsychological performance measures and domains of relevance to exploration class missions?